NEKTAR THERAPEUTICS — Director's Dealing 2014

Nov 4, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2014-11-03

Reporting Person: Labrucherie Gil M (SVP & General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-11-03	Common Stock	M	9900	$11.3800	Acquired	13651	Direct
2014-11-03	Common Stock	S	9900	$13.78	Disposed	3751	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-11-03	Stock Option	$11.3800	M	9900	Disposed	2015-03-15	Common Stock (9900)	Direct

Footnotes

F1: This transaction was made pursuant to a Rule 10b5-1 trading plan.

F2: This number includes 997 shares held by the reporting person in the Issuer's 401(k) plan. The acquisition of these shares under that plan is exempt under Rule 16b-3(c).

F3: This number includes 250 shares held by the reporting person in his account under the Issuer's ESPP. The acquisition of these shares under that plan is exempt under Rule 16b-3(c).